Al's Comment:

 This study shows a small improvement with Optune by itself compared to standard treatments.  Enough to show Optune does have a positive effect but not enough to use Optune by itself for recurrent Glioblastoma (or to use the standard treatments either).  Further study is needed combining Optune with other treatments to make meaningful gains in survival.

Posted on: 04/27/2020

EF-19 - A post-approval registry study of TTFields for the treatment of recurrent glioblastoma (GBM)


Click HERE to return to brain tumor news headlines.

Our privacy / cookie policy has changed.
Click HERE to read it!